Trinity Capital, Inc. TRIN 深 沪
等待开盘 04-02 09:30:00 美东时间
14.79
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 14.79
- 总市值 12.30亿
- 52周最高 16.8614
- 市盈率 静 7.56
- 换手率 0.00%
- 52周最低 11.68
- 委 比 0.00%
- 总股本 8317.49万
- 历史最高 16.8614
- 量 比 0
- 振 幅 0.00%
- 历史最低 2.99
- 每 手 1
- 风险率 1.12%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Trinity Capital Commits $50M For Sage Health
Trinity Capital Inc. (Nasdaq: TRIN) (the "Company"), a leading international alternative asset manager, today announced the commitment of $50 million in growth capital to Sage Health ("Sage"), a full-risk primary care
03-27 21:08
BRIEF-Trinity Capital Provides $50 Million In Growth Capital To Sage Health To Expand Senior-Focused Primary Care Wellness Centers
BRIEF-Trinity Capital Provides $50 Million In Growth Capital To Sage Health To Expand Senior-Focused Primary Care Wellness Centers Trinity Capital Inc TRIN.O : TRINITY CAPITAL PROVIDES $50 MILLION IN GROWTH CAPITAL TO SAGE HEALTH TO EXPAND SENIOR-FOCUSED PRIMARY CARE WELLNESS CENTERS Source text: ID
03-27 21:00
Trinity Capital declares $0.17 dividend
Trinity Capital (TRIN) declares $0.17/share monthly dividend, in line with previous. Forward yield 14.0% Payable April 30; for shareholders of record April 15; ex-div April 15. Payable May 29; for sha...
03-19 04:35
BRIEF-Capital Southwest And Trinity Capital Announce Formation Of New Joint Venture
BRIEF-Capital Southwest And Trinity Capital Announce Formation Of New Joint Venture March 16 (Reuters) - Capital Southwest Corp CSWC.O : CAPITAL SOUTHWEST AND TRINITY CAPITAL ANNOUNCE FORMATION OF NEW JOINT VENTURE Source text: ID:nPn67CrGXa Further company coverage: CSWC.O (( Reuters.Briefs@thomson
03-16 20:13
Private credit stress grows as Quant ratings turn cautious on several firms
Concerns are mounting across the roughly $2T private credit market after a series of recent credit issues and fund restrictions put the fast-growing sector under fresh scrutiny, pressuring shares of s...
03-12 21:24
Candel Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights
Candel Therapeutics announced plans to initiate a pivotal phase 3 clinical trial for aglatimagene besadenovec (CAN-2409) in metastatic, non-squamous non-small cell lung cancer (NSCLC) in Q2 2026 and submitted a Biologics License Application (BLA) for aglatimagene in localized, intermediate-to-high-risk prostate cancer in Q4 2026. The company received IND clearance for linoserpaturev (CAN-3110) in recurrent high-grade glioma (rHGG) and secured a $...
03-12 12:05
Trinity Capital commits $35M in growth capital to Neuros Medical
Trinity Capital (TRIN) on Tuesday said it has committed $35 million in growth capital to Neuros Medical. The financing will support the expansion and commercialization of Neuros Medical’s Altius Direc...
03-10 21:24
Trinity Capital CEO Kyle Steven Brown Acquires Common Shares
Trinity Capital CEO Kyle Steven Brown Acquires Common Shares Kyle Steven Brown, CEO, President and CIO of Trinity Capital Inc., reported acquiring 3,333 shares of the company’s common stock. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Tec
03-05 10:00
Trinity Capital NII of $0.52 in-line
Trinity Capital press release (TRIN): Q4 NII of $0.52 in-line. Total investment income of $83.24M (+17.5% Y/Y) beats by $3.23M. Net Asset Value ("NAV") of $1.1 billion, or $13.42 per share at the end ...
02-25 21:07
Trinity Cap Q4 EPS $0.52, Inline, Sales $83.235M Beat $80.713M Estimate
Trinity Cap (NASDAQ:TRIN) reported quarterly earnings of $0.52 per share which met the analyst consensus estimate. This is a 7.14 percent decrease over earnings of $0.56 per share from the same period last year. The
02-25 21:03
